CIGNA Co. (NYSE:CI) EVP Nicole S. Jones sold 20,312 shares of CIGNA stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $160.04, for a total transaction of $3,250,732.48. Following the transaction, the executive vice president now owns 44,737 shares in the company, valued at approximately $7,159,709.48. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of CIGNA Co. (NYSE:CI) traded down 0.39% during mid-day trading on Friday, reaching $159.48. 1,607,577 shares of the company’s stock were exchanged. CIGNA Co. has a 1-year low of $115.03 and a 1-year high of $164.88. The stock has a market capitalization of $40.83 billion, a PE ratio of 21.29 and a beta of 0.53. The company’s 50 day moving average is $155.52 and its 200 day moving average is $145.25.

CIGNA (NYSE:CI) last posted its quarterly earnings data on Friday, May 5th. The health services provider reported $2.77 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.44 by $0.33. The business had revenue of $10.39 billion for the quarter, compared to the consensus estimate of $10.11 billion. CIGNA had a net margin of 4.71% and a return on equity of 15.77%. The company’s revenue was up 5.1% compared to the same quarter last year. During the same period last year, the firm posted $2.46 earnings per share. Equities research analysts anticipate that CIGNA Co. will post $9.63 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for CIGNA (NYSE:CI)

WARNING: This story was published by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/05/19/cigna-co-ci-evp-sells-3250732-48-in-stock.html.

A number of research analysts recently weighed in on the stock. Deutsche Bank AG lifted their target price on shares of CIGNA from $172.00 to $175.00 and gave the company a “buy” rating in a research note on Wednesday, May 10th. Stifel Nicolaus lifted their target price on shares of CIGNA from $170.00 to $175.00 and gave the company a “buy” rating in a research note on Monday. Royal Bank of Canada lifted their target price on shares of CIGNA from $172.00 to $177.00 and gave the company an “outperform” rating in a research note on Monday. Jefferies Group LLC lifted their target price on shares of CIGNA from $178.00 to $183.00 and gave the company a “buy” rating in a research note on Monday. Finally, Zacks Investment Research upgraded shares of CIGNA from a “hold” rating to a “buy” rating and set a $175.00 target price on the stock in a research note on Tuesday, April 25th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $167.57.

A number of institutional investors have recently bought and sold shares of CI. American Beacon Advisors Inc. bought a new position in CIGNA during the first quarter valued at about $102,000. Baystate Wealth Management LLC increased its position in CIGNA by 436.1% in the first quarter. Baystate Wealth Management LLC now owns 772 shares of the health services provider’s stock valued at $116,000 after buying an additional 628 shares during the last quarter. Founders Capital Management bought a new position in CIGNA during the first quarter valued at about $117,000. Mckinley Capital Management LLC Delaware bought a new position in CIGNA during the first quarter valued at about $122,000. Finally, Live Your Vision LLC bought a new position in CIGNA during the third quarter valued at about $113,000. 85.65% of the stock is currently owned by institutional investors and hedge funds.

CIGNA Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

5 Day Chart for NYSE:CI

Receive News & Ratings for CIGNA Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA Co. and related companies with MarketBeat.com's FREE daily email newsletter.